Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis

Abstract According to the World Health Organization (WHO), 10.0 million people worldwide contracted tuberculosis (TB) in 2019, with 1.4 million people dying from the disease. Multidrug-resistant tuberculosis is caused by…

Continue ReadingUpdates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis

Efficacy and safety of intravenous fosfomycin for the treatment of difficult-to-treat Gram-negative bacterial infections

Introduction While many antimicrobial classes and compounds are potent in vitro, they may be accompanied with excessive toxicity or poor pharmacokinetics, limiting their clinical value in specific situations. As a…

Continue ReadingEfficacy and safety of intravenous fosfomycin for the treatment of difficult-to-treat Gram-negative bacterial infections

An Update on Eight “New” Antibiotics against Multidrug-Resistant Gram-Negative Bacteria

Introduction Gram-negative bacteria cause two-thirds of infections in intensive care units (ICUs), and antibiotic resistance among these bacteria is a serious issue. Several multidrug-resistant Gram-negative bacteria, including carbapenem-resistant Acinetobacter baumannii,…

Continue ReadingAn Update on Eight “New” Antibiotics against Multidrug-Resistant Gram-Negative Bacteria

SepINav (Sepsis ICU Navigator): A data-driven software tool for sepsis monitoring and intervention using Bayesian Online Change Point Detection

Introduction The alarmingly rising rates of sepsis and septic shock, as well as the related mortality, morbidity, and yearly treatment expenditures among ICU patients, are a growing source of worry.…

Continue ReadingSepINav (Sepsis ICU Navigator): A data-driven software tool for sepsis monitoring and intervention using Bayesian Online Change Point Detection

Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients

Introduction Over the past 20 years or so, invasive fungal diseases (IFDs) have become one of the main causes of death in hematological patients treated with high-intensity chemotherapy and/or a…

Continue ReadingReal-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients

Bioresponsive micro-to-nano albumin-based systems for targeted drug delivery against complex fungal infections

Introduction Cryptococcus neoformans is a life-threatening invasive fungal disease. It is more than merely a multi-organ infection; the fungus' intracellular survival and extracellular proliferation play essential roles in the pathophysiology…

Continue ReadingBioresponsive micro-to-nano albumin-based systems for targeted drug delivery against complex fungal infections

Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method

Introduction The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic, putting enormous strain on healthcare systems around the world. Depending on the admission criteria and available resources,…

Continue ReadingExpert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method

New Microbiological Techniques for the Diagnosis of Bacterial Infections and Sepsis in ICU Patients

Introduction Bacterial infections and sepsis cause major morbidity and death in patients hospitalised to the intensive care unit, and their management is complicated by the rise in antibiotic resistance worldwide.…

Continue ReadingNew Microbiological Techniques for the Diagnosis of Bacterial Infections and Sepsis in ICU Patients